Buprenorphine vs Ipilimumab

Buprenorphine vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Ipilimumab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Ipilimumab — Antibody.